Serrano-Rubio Alejandro, Ruiz-Treviño Armando S, Orenday-Barraza Jose M, Vázquez-Gregorio Rafael, Lee Angel, Nathal Edgar
Department of Vascular Neurosurgery, National Institute of Neurology and Neurosurgery "Manuel Velasco Suárez", Mexico City, Mexico.
Department of Vascular Neurosurgery, National Institute of Neurology and Neurosurgery "Manuel Velasco Suárez", Mexico City, Mexico.
World Neurosurg. 2018 Sep;117:e329-e334. doi: 10.1016/j.wneu.2018.06.024. Epub 2018 Jun 12.
To characterize dynamic changes of arteriovenous malformation using a microscope-integrated technique at the moment of performing intraoperative fluorescein videoangiography (FL-VAG) at each of the resection phases.
We prospectively recruited 12 patients with arteriovenous malformations and used FL-VAG as an ancillary technique for resection of the lesion. We analyzed transit time (TT) of FL in arterial feeders (arterial transit time [TTa]) and draining veins (venous transit time [TTv]) during the different stages of resection. To achieve this, we recorded 3 values of TT of FL (TTa, initial TTv, final TTv); when final TTv was markedly slower than initial TTv, we hypothesized that the nidus was devascularized enough and could be safely removed.
No mortality or morbidity was related to use of FL. In most cases, TT values of arterial feeders and draining veins allowed an easier distinction between them. At advanced stages of resection, FL-VAG assessed increase in TTv (venous blood slower or absent), suggesting that most feeding arteries had been obliterated, indicating the appropriate moment for nidus removal. Optimal dose of FL was a 75-mg bolus followed by injection of 20 mL of saline solution.
FL-VAG allows a distinction of normal from abnormal flow in draining vessels and might help the surgeon to decide when the nidus can be safely removed. This is the first study prospectively evaluating this technique, and it proposes an ideal dose for brain arteriovenous malformation surgery, in contrast to doses used in tumor cases.
在动静脉畸形切除的各个阶段进行术中荧光素视频血管造影(FL-VAG)时,使用显微镜集成技术来描述动静脉畸形的动态变化。
我们前瞻性招募了12例动静脉畸形患者,并将FL-VAG用作病变切除的辅助技术。我们分析了切除不同阶段荧光素在动脉供血支(动脉通过时间[TTa])和引流静脉(静脉通过时间[TTv])中的通过时间(TT)。为此,我们记录了荧光素的3个TT值(TTa、初始TTv、最终TTv);当最终TTv明显慢于初始TTv时,我们假设畸形团已充分去血管化,可以安全切除。
未发生与使用荧光素相关的死亡或并发症。在大多数情况下,动脉供血支和引流静脉的TT值使它们之间更容易区分。在切除的后期阶段,FL-VAG评估了TTv的增加(静脉血流减慢或无血流),这表明大多数供血动脉已闭塞,提示了切除畸形团的合适时机。荧光素的最佳剂量是75mg推注,随后注射20mL生理盐水。
FL-VAG能够区分引流血管中的正常血流与异常血流,并可能有助于外科医生决定何时可以安全切除畸形团。这是第一项前瞻性评估该技术的研究,并且它提出了脑动静脉畸形手术的理想剂量,这与肿瘤病例中使用的剂量不同。